{
    "body_text": [
        {
            "endOffset": 33156,
            "parents": [],
            "secId": "s0110",
            "sentence": "Specifically, the findings and conclusions in this paper are those of the authors and do not necessarily represent the views of their respective institutions.",
            "startOffset": 32998,
            "title": "Disclaimer"
        },
        {
            "endOffset": 11978,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "It has lesser spatial resolution and is less sensitive for the detection of neonatal seizures compared to long term monitoring by conventional EEG [10,11].",
            "startOffset": 11823,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 15881,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The results were limited to those published since 2005.",
            "startOffset": 15826,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for neonatal encephalopathy as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 12226,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Abnormalities on the neonatal EEG such as discontinuity of the background or central sharp waves are not specific and will vary depending on external factors such as gestational age, body temperature during therapeutic cooling and medications [7].",
            "startOffset": 11979,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 11822,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This recording compresses the time scale of conventional EEG.",
            "startOffset": 11761,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 32411,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "Whether the date of onset (see footnote 4) and/or the date of first observation (see footnote 5) and/or the date of diagnosis (see footnote 6) was used for analysis; and",
            "startOffset": 32242,
            "title": "Data presentation"
        },
        {
            "endOffset": 19560,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0045",
            "sentence": "Relation to the patient (e.g., immuniser [clinician, nurse], family member [indicate relationship], other).",
            "startOffset": 19453,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 19738,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                },
                {
                    "id": "s0050",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0055",
            "sentence": "For all cases and/or all study participants (including mothers and infants), as appropriate, the following information should be recorded:",
            "startOffset": 19600,
            "title": "Demographics"
        },
        {
            "endOffset": 11217,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Electrographic pathological patterns correlate with neonatal seizures during seizure recording and subtle or subclinical seizures can often only be diagnosed by EEG monitoring.",
            "startOffset": 11041,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 21624,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0065",
            "sentence": "Route and method of administration (e.g. intramuscular, intradermal, subcutaneous, and needle-free (including type and size), other injection devices).",
            "startOffset": 21473,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 11760,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Amplitude integrated EEG (aEEG) is becoming widely used by neonatologists.",
            "startOffset": 11686,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 19450,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0045",
            "sentence": "Name and contact information of the investigator responsible for the subject, as applicable.",
            "startOffset": 19358,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 31525,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "It is essential to specify:",
            "startOffset": 31498,
            "title": "Data presentation"
        },
        {
            "endOffset": 11453,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Once anti-seizure medications are administered, up to 58% of treated neonates exhibit electro-clinical uncoupling, in which the clinical signs of their seizures vanish despite the persistence of subclinical electrographic seizures [9].",
            "startOffset": 11218,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 11685,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Also EEG is not always readily available for recording in the NICU.",
            "startOffset": 11618,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 13469,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Furthermore, the diagnosis of \u201cencephalopathy of prematurity\u201d is heavily based on neuroanatomical changes seen on MRI or autopsies rather than acute clinical signs [2,6].",
            "startOffset": 13299,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 23930,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0070",
            "sentence": "Objective clinical evidence supporting classification of the event as \u201cserious\u201d.10",
            "startOffset": 23433,
            "title": "The adverse event"
        },
        {
            "endOffset": 13298,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "When assessing encephalopathy in a newborn younger than 35 weeks of gestation, normal neurological development may prevent specific behavioral reactions and reflexes to be tested, making semiology unreliable.",
            "startOffset": 13090,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 10546,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The common denominator in neonatal encephalopathy is the loss of homeostasis which can lead to abnormal brain function and potentially to brain structural changes [2\u20134].",
            "startOffset": 10377,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 15629,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "This search resulted in several general book chapters discussing various types of neonatal encephalopathy.",
            "startOffset": 15523,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for neonatal encephalopathy as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 21127,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0065",
            "sentence": "Date and time of maternal immunisation(s).",
            "startOffset": 21085,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 9653,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The Sarnat criteria remain as the most commonly accepted classification [2,3].",
            "startOffset": 9575,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 32016,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "The search strategy in surveillance databases;",
            "startOffset": 31970,
            "title": "Data presentation"
        },
        {
            "endOffset": 14158,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This definition is to be equally applied in vaccinated or unvaccinated populations.",
            "startOffset": 14075,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 21652,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0065",
            "sentence": "Needle length and gauge.",
            "startOffset": 21628,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 17192,
            "parents": [],
            "secId": "s0030",
            "sentence": "Level 3 of diagnostic certainty (Possible)",
            "startOffset": 17150,
            "title": "Case definition of neonatal encephalopathy3For Seizure definition see Ref. [12].3"
        },
        {
            "endOffset": 30802,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "Although immunisation safety surveillance systems denominator data are usually not readily available, attempts should be made to identify approximate denominators.",
            "startOffset": 30639,
            "title": "Data presentation"
        },
        {
            "endOffset": 32997,
            "parents": [],
            "secId": "s0110",
            "sentence": "They do not necessarily represent the official positions of each participant\u2019s organisation (e.g., government, university, or corporation).",
            "startOffset": 32858,
            "title": "Disclaimer"
        },
        {
            "endOffset": 32153,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "The instrument of data collection (e.g. standardised questionnaire, diary card, report form);",
            "startOffset": 32060,
            "title": "Data presentation"
        },
        {
            "endOffset": 15688,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "There were no Cochrane reviews that focused on this topic.",
            "startOffset": 15630,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for neonatal encephalopathy as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 31144,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "The incidence of cases in the study population should be presented and clearly identified as such in the text.",
            "startOffset": 31034,
            "title": "Data presentation"
        },
        {
            "endOffset": 18580,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0040",
            "sentence": "These guidelines represent a desirable standard for the collection of data on availability following maternal immunisation to allow for comparability of data, and are recommended as an addition to data collected for the specific study question and setting.",
            "startOffset": 18324,
            "title": "Data collection"
        },
        {
            "endOffset": 23380,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0070",
            "sentence": "Treatment given for Neonatal Encephalopathy, especially specify what and dosing.",
            "startOffset": 23300,
            "title": "The adverse event"
        },
        {
            "endOffset": 15392,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "These platforms included electronic books, systematic reviews, and other journal literature.",
            "startOffset": 15300,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for neonatal encephalopathy as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 25835,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0080",
            "sentence": "Reported events should be classified in one of the following five categories including the three levels of diagnostic certainty.",
            "startOffset": 25707,
            "title": "Data analysis"
        },
        {
            "endOffset": 32857,
            "parents": [],
            "secId": "s0110",
            "sentence": "The findings, opinions and assertions contained in this consensus document are those of the individual scientific professional members of the working group.",
            "startOffset": 32701,
            "title": "Disclaimer"
        },
        {
            "endOffset": 12832,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The Task Force on Neonatal Encephalopathy group on Neonatal Encephalopathy and Neurological outcome published in 2014 a comprehensive document defining Neonatal encephalopathy as \u201ca clinical syndrome in an infant born at or beyond 35 weeks of gestation, manifested by a subnormal level of consciousness or seizures, and often accompanied by difficulty with initiating and maintaining respiration and depression of tone and reflexes\u201d [5].",
            "startOffset": 12395,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 15165,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "To guide the decision-making for the case definition and guidelines, a literature search was performed using Embase.com (Medline/PubMed + Embase); ClinicalKey (eBooks); ScienceDirect (eBooks); StatRef (eBooks) and the Cochrane Library.",
            "startOffset": 14930,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for neonatal encephalopathy as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 31969,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "The characteristics of the surveillance system (e.g. population served, mode of report solicitation);",
            "startOffset": 31868,
            "title": "Data presentation"
        },
        {
            "endOffset": 9050,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Encephalopathy is a general term used to define disease, malfunction or damage of the brain.",
            "startOffset": 8958,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 23429,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0070",
            "sentence": "Outcome (see footnote 8) at last observation.",
            "startOffset": 23384,
            "title": "The adverse event"
        },
        {
            "endOffset": 18906,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0040",
            "sentence": "Investigators developing a data collection tool based on these data collection guidelines also need to refer to the criteria in the case definition, which are not repeated in these guidelines.",
            "startOffset": 18714,
            "title": "Data collection"
        },
        {
            "endOffset": 22926,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0070",
            "sentence": "Concurrent signs, symptoms, and diseases.",
            "startOffset": 22885,
            "title": "The adverse event"
        },
        {
            "endOffset": 17073,
            "parents": [],
            "secId": "s0030",
            "sentence": "Abnormal level of alertness or seizures",
            "startOffset": 17034,
            "title": "Case definition of neonatal encephalopathy3For Seizure definition see Ref. [12].3"
        },
        {
            "endOffset": 16234,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "There is hence no uniformly accepted definition of Neonatal Encephalopathy following immunisations.",
            "startOffset": 16135,
            "title": "Temporal versus causal association with maternal immunisation"
        },
        {
            "endOffset": 11040,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The EEG is the most specific test to confirm and diagnose that a clinical paroxysm is epileptic in origin [9].",
            "startOffset": 10930,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 31273,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "If the distribution of data is skewed, median and range are usually the more appropriate statistical descriptors than a mean.",
            "startOffset": 31148,
            "title": "Data presentation"
        },
        {
            "endOffset": 17034,
            "parents": [],
            "secId": "s0030",
            "sentence": "Level 2 of diagnostic certainty (Probable)",
            "startOffset": 16992,
            "title": "Case definition of neonatal encephalopathy3For Seizure definition see Ref. [12].3"
        },
        {
            "endOffset": 18070,
            "parents": [],
            "secId": "s0035",
            "sentence": "The availability of information may vary depending upon resources, geographical region, and whether the source of information is a prospective clinical trial, a post-marketing surveillance or epidemiological study, or an individual report of Neonatal encephalopathy.",
            "startOffset": 17804,
            "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 14930,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The composition of the working and reference group as well as results of the web-based survey completed by the reference group with subsequent discussions in the working group can be viewed at: http://www.brightoncollaboration.org/internet/en/index/working_groups.html.",
            "startOffset": 14661,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for neonatal encephalopathy as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 29563,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "These guidelines represent a desirable standard for the presentation and publication of data on Neonatal Encephalopathy following maternal immunisation to allow for comparability of data, and are recommended as an addition to data presented for the specific study question and setting.",
            "startOffset": 29278,
            "title": "Data presentation"
        },
        {
            "endOffset": 31030,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "The source of the denominator data should be reported and calculations of estimates be described (e.g. manufacturer data like total doses distributed, reporting through Ministry of Health, coverage/population based data, etc.).",
            "startOffset": 30803,
            "title": "Data presentation"
        },
        {
            "endOffset": 20428,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                },
                {
                    "id": "s0050",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0060",
            "sentence": "Past medical history, including hospitalisations, underlying diseases/disorders, pre-immunisation signs and symptoms including identification of indicators for, or the absence of, a history of allergy to vaccines, vaccine components or medications; food allergy; allergic rhinitis; eczema; asthma.",
            "startOffset": 20131,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 15825,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The journal literature search produced 33 results that included subject headings or keywords for vaccines, pregnancy and encephalopathy.",
            "startOffset": 15689,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for neonatal encephalopathy as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 8646,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "To improve comparability of vaccine safety data, the acute neonatal encephalopathy working group has developed a case definition and guidelines neonatal encephalopathy applicable in study settings with different availability of resources, in healthcare settings that differ by availability of and access to health care, and in different geographic regions.",
            "startOffset": 8290,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 32241,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "Whether the day of immunisation was considered \u201cday one\u201d or \u201cday zero\u201d in the analysis;",
            "startOffset": 32154,
            "title": "Data presentation"
        },
        {
            "endOffset": 10801,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Investigations such as magnetic resonance Imaging and neurophysiological technologies such as electroencephalography and evoked potentials are aids in exploring the severity and prognosis of neonatal encephalopathy, but are not required for its diagnosis.",
            "startOffset": 10546,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 14075,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Considering the limitations for diagnosing and timing encephalopathies in the preterm newborn, this review defines Neonatal encephalopathy as a clinical syndrome presenting with abnormal functioning of the central nervous system, in the earliest days of life in an newborn (up to 28 days of life) born at or beyond 35 weeks of gestation, manifested by an abnormal level of alertness or seizures, and often accompanied by difficulty with initiating and maintaining respiration and depression of tone that may be due to a variety of etiologies including hypoxia/ischemia, metabolic disturbance, or infection.",
            "startOffset": 13469,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 21081,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0065",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 20975,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 32059,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "Comparison group(s), if used for analysis;",
            "startOffset": 32017,
            "title": "Data presentation"
        },
        {
            "endOffset": 10106,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The reason is that other etiologies are often reported as a specific diagnosis, as in the case of inborn errors of metabolism (e.g. non-ketotic hyperglycinemia), infections (e.g. meningitis) and other specific causes.",
            "startOffset": 9889,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 32691,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "Use of this case definition for Neonatal encephalopathy, in the abstract or methods section of a publication.14",
            "startOffset": 32412,
            "title": "Data presentation"
        },
        {
            "endOffset": 24088,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0070",
            "sentence": "Exposures other than the immunisation 24 h before and after immunisation (e.g. food, environmental) considered potentially relevant to the reported event.",
            "startOffset": 23934,
            "title": "The adverse event"
        },
        {
            "endOffset": 30309,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "Data on Neonatal Encephalopathy events should be presented in accordance with data collection guidelines 1\u201324 and data analysis guidelines 31\u201336",
            "startOffset": 30165,
            "title": "Data presentation"
        },
        {
            "endOffset": 12395,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Therefore, as per World Health Organization guidelines on neonatal seizures, the most practical method of diagnosis is the clinical recognition of neonatal seizures [8].",
            "startOffset": 12226,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 16914,
            "parents": [],
            "secId": "s0030",
            "sentence": "Abnormal level of alertness or seizures (see footnote 1)",
            "startOffset": 16858,
            "title": "Case definition of neonatal encephalopathy3For Seizure definition see Ref. [12].3"
        },
        {
            "endOffset": 18713,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0040",
            "sentence": "The guidelines are not intended to guide the primary reporting of Neonatal Encephalopathy to a surveillance system or study monitor.",
            "startOffset": 18581,
            "title": "Data collection"
        },
        {
            "endOffset": 12983,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "It was the consensus of our group to replace the word \u201cconsciousness\u201d with the word \u201calertness\u201d since the definition of \u201cconsciousness\u201d is more vague.",
            "startOffset": 12833,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 17130,
            "parents": [],
            "secId": "s0030",
            "sentence": "Difficulty with initiating and maintaining respiration",
            "startOffset": 17076,
            "title": "Case definition of neonatal encephalopathy3For Seizure definition see Ref. [12].3"
        },
        {
            "endOffset": 31497,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "Any publication of data on Neonatal encephalopathy should include a detailed description of the methods used for data collection and analysis as possible.",
            "startOffset": 31343,
            "title": "Data presentation"
        },
        {
            "endOffset": 18306,
            "parents": [],
            "secId": "s0035",
            "sentence": "Also, as explained in more detail in the overview paper, these guidelines have been developed by this working group for guidance only, and are not to be considered a mandatory requirement for data collection, analysis, or presentation.",
            "startOffset": 18071,
            "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 19355,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0045",
            "sentence": "Name and contact information of person reporting4 and/or diagnosing the Neonatal Encephalopathy as specified by country-specific data protection law.",
            "startOffset": 19068,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 20672,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                },
                {
                    "id": "s0050",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0060",
            "sentence": "Any medication history (other than treatment for the event described) prior to, during, and after immunisation including prescription and non-prescription medication as well as medication or treatment with long half-life or long term effect.",
            "startOffset": 20431,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 23296,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0070",
            "sentence": "Results of laboratory examinations, surgical and/or pathological findings and diagnoses if present.",
            "startOffset": 23197,
            "title": "The adverse event"
        },
        {
            "endOffset": 19933,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                },
                {
                    "id": "s0050",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0055",
            "sentence": "Date of birth, age, and sex.",
            "startOffset": 19905,
            "title": "Demographics"
        },
        {
            "endOffset": 25978,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0080",
            "sentence": "Events that meet the case definition should be classified according to the levels of diagnostic certainty as specified in the case definition.",
            "startOffset": 25836,
            "title": "Data analysis"
        },
        {
            "endOffset": 11617,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "EEG however has important technical limitations in the recording of some epileptic seizures, particularly those originating in mesial or midline areas of the brain.",
            "startOffset": 11453,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 30639,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "Data should be presented with numerator and denominator (n/N) (and not only in percentages), if available.",
            "startOffset": 30533,
            "title": "Data presentation"
        },
        {
            "endOffset": 9888,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Over the years, the term \u201cneonatal encephalopathy\u201d, has been used by many as a synonym of \u201cHypoxic-ischemic encephalopathy\u201d.",
            "startOffset": 9764,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 25703,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0080",
            "sentence": "The following guidelines represent a desirable standard for analysis of data on Neonatal encephalopathy to allow for comparability of data, and are recommended as an addition to data analysed for the specific study question and setting.",
            "startOffset": 25467,
            "title": "Data analysis"
        },
        {
            "endOffset": 9442,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Nevertheless, specific clinical signs reflecting neurological function correlate with the overall severity of the encephalopathy.",
            "startOffset": 9313,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 17317,
            "parents": [],
            "secId": "s0030",
            "sentence": "Abnormal level of alertness or seizures without difficulty with initiating and maintaining respiration nor depression of tone",
            "startOffset": 17192,
            "title": "Case definition of neonatal encephalopathy3For Seizure definition see Ref. [12].3"
        },
        {
            "endOffset": 31339,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "However, the mean and standard deviation should also be provided.",
            "startOffset": 31274,
            "title": "Data presentation"
        },
        {
            "endOffset": 31627,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "The method, frequency and duration of monitoring for Acute Neonatal encephalopathy;",
            "startOffset": 31544,
            "title": "Data presentation"
        },
        {
            "endOffset": 16757,
            "parents": [],
            "secId": "s0030",
            "sentence": "For All Levels of Diagnostic Certainty",
            "startOffset": 16719,
            "title": "Case definition of neonatal encephalopathy3For Seizure definition see Ref. [12].3"
        },
        {
            "endOffset": 16858,
            "parents": [],
            "secId": "s0030",
            "sentence": "Level 1 of diagnostic certainty (Definite)",
            "startOffset": 16816,
            "title": "Case definition of neonatal encephalopathy3For Seizure definition see Ref. [12].3"
        },
        {
            "endOffset": 9763,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Neonatal encephalopathy has several potential etiologies and acute hypoxia-ischemia is the most studied cause.",
            "startOffset": 9653,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 17722,
            "parents": [],
            "secId": "s0035",
            "sentence": "It was the consensus of the Brighton Collaboration Neonatal Encephalopathy Working Group to recommend the following guidelines to enable meaningful and standardized collection, analysis, and presentation of information about Neonatal encephalopathy.",
            "startOffset": 17473,
            "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 15523,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The following three search parameters which included a variety of synonyms were combined; pregnancy, vaccines, and encephalopathy.",
            "startOffset": 15393,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for neonatal encephalopathy as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 9574,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "These clinical signs have been grouped in stages, usually three of them: mild, moderate and severe as in the Sarnat classification.",
            "startOffset": 9443,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 30529,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "Terms to describe Neonatal Encephalopathy such as \u201clow-grade\u201d, \u201cmild\u201d, \u201cmoderate\u201d, \u201chigh\u201d, \u201csevere\u201d or \u201csignificant\u201d are highly subjective, prone to wide interpretation, and should be avoided, unless clearly defined.",
            "startOffset": 30313,
            "title": "Data presentation"
        },
        {
            "endOffset": 20738,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                },
                {
                    "id": "s0050",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0060",
            "sentence": "(e.g. immunoglobulins, blood transfusion and immunosuppressants).",
            "startOffset": 20673,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 8958,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "They are grounded on both expert opinion and a systematic literature review related to the assessment of acute neonatal encephalopathy as an adverse event following immunisation and to the diagnosis of acute neonatal encephalopathy in humans.",
            "startOffset": 8716,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 15299,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Several different research platforms were utilized in this search for references focused on maternal vaccination and encephalopathies.",
            "startOffset": 15165,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for neonatal encephalopathy as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 9312,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Defining altered mental state in the newborn is significantly more challenging than in the adult and there are no established direct measures to determine level of consciousness in the newborn.",
            "startOffset": 9119,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 19982,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                },
                {
                    "id": "s0050",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0055",
            "sentence": "For infants: Gestational age and birth weight.",
            "startOffset": 19936,
            "title": "Demographics"
        },
        {
            "endOffset": 8715,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The definition and guidelines were developed through group consensus.",
            "startOffset": 8646,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 20943,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                },
                {
                    "id": "s0050",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0060",
            "sentence": "Immunisation history (i.e. previous immunisations and any adverse event following immunisation (AEFI)), in particular occurrence of Acute Neonatal Encephalopathy after a previous maternal immunisation.",
            "startOffset": 20742,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 14660,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Following the process described on the Brighton Collaboration Website http://www.brightoncollaboration.org/internet/en/index/process.html, the Brighton Collaboration Neonatal Encephalopathy Working Group was formed in 2016 and included members of clinical, academic, public health and industry background.",
            "startOffset": 14355,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for neonatal encephalopathy as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 16637,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0025",
            "sentence": "Similar to all Brighton Collaboration case definitions and guidelines, review of the definition with its guidelines is planned on a regular basis (i.e. every three to five years) or more often if needed.",
            "startOffset": 16434,
            "title": "Periodic review"
        },
        {
            "endOffset": 17803,
            "parents": [],
            "secId": "s0035",
            "sentence": "However, implementation of all guidelines might not be possible in all settings.",
            "startOffset": 17723,
            "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 23196,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0070",
            "sentence": "Method of measurement (e.g. type of thermometer, oral or other route, duration of measurement, etc.);",
            "startOffset": 23095,
            "title": "The adverse event"
        },
        {
            "endOffset": 16134,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "There are no reports of encephalopathy following immunisation in the pregnant woman or the newborn.",
            "startOffset": 16035,
            "title": "Temporal versus causal association with maternal immunisation"
        },
        {
            "endOffset": 16816,
            "parents": [],
            "secId": "s0030",
            "sentence": "Newborn (1\u201328 days) born at or beyond 35 weeks of gestation",
            "startOffset": 16757,
            "title": "Case definition of neonatal encephalopathy3For Seizure definition see Ref. [12].3"
        },
        {
            "endOffset": 16416,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "This is a missed opportunity, as data comparability across trials or surveillance systems would facilitate data interpretation and promote the scientific understanding of the event.",
            "startOffset": 16235,
            "title": "Temporal versus causal association with maternal immunisation"
        },
        {
            "endOffset": 13090,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "We also considered it necessary to include in the definition the concept of multiple potential etiologies.",
            "startOffset": 12984,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 16971,
            "parents": [],
            "secId": "s0030",
            "sentence": "Difficulty with initiating and maintaining respiration",
            "startOffset": 16917,
            "title": "Case definition of neonatal encephalopathy3For Seizure definition see Ref. [12].3"
        },
        {
            "endOffset": 21469,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0065",
            "sentence": "The anatomical sites (including left or right side) of all immunisations (e.g. vaccine A in proximal left lateral thigh, vaccine B in left deltoid).",
            "startOffset": 21321,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 22032,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0070",
            "sentence": "Clinical description of signs and symptoms of Neonatal Encephalopathy, and if there was medical confirmation of the event (i.e. patient seen by physician).",
            "startOffset": 21877,
            "title": "The adverse event"
        },
        {
            "endOffset": 30039,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "Additionally, it is recommended to refer to existing general guidelines for the presentation and publication of randomised controlled trials, systematic reviews, and meta-analyses of observational studies in epidemiology (e.g. statements of Consolidated Standards of Reporting Trials (CONSORT), of improving the quality of reports of meta-analyses of randomised controlled trials (QUORUM), and of meta-analysis Of Observational Studies in Epidemiology (MOOSE), respectively).",
            "startOffset": 29564,
            "title": "Data presentation"
        },
        {
            "endOffset": 19902,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                },
                {
                    "id": "s0050",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0055",
            "sentence": "Case/study participant identifiers (e.g. first name initial followed by last name initial) or code (or in accordance with country-specific data protection laws).",
            "startOffset": 19741,
            "title": "Demographics"
        },
        {
            "endOffset": 19047,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0045",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 18941,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 31867,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "The type of surveillance (e.g. passive or active surveillance);",
            "startOffset": 31804,
            "title": "Data presentation"
        },
        {
            "endOffset": 21317,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0065",
            "sentence": "Description of vaccine(s) (name of vaccine, manufacturer, lot number, dose (e.g. 0.25 mL, 0.5 mL, etc.) and number of dose if part of a series of immunisations against the same disease).",
            "startOffset": 21131,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 23094,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0070",
            "sentence": "Values and units of routinely measured parameters (e.g. temperature, blood pressure) \u2013 in particular those indicating the severity of the event;",
            "startOffset": 22950,
            "title": "The adverse event"
        },
        {
            "endOffset": 22881,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                }
            ],
            "secId": "s0070",
            "sentence": "Date/time of onset,5 first observation6 and diagnosis,7 end of episode8 and final outcome.9",
            "startOffset": 22036,
            "title": "The adverse event"
        },
        {
            "endOffset": 10930,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "MRI brain can be reported normal in 15\u201330% of cases of confirmed mild cases (Sarnat 1) of hypoxic ischemic encephalopathy [1,5].",
            "startOffset": 10802,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 20128,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                },
                {
                    "id": "s0040",
                    "title": "Data collection"
                },
                {
                    "id": "s0050",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0060",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 20022,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 9118,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The major symptom of encephalopathy is an altered mental state [1].",
            "startOffset": 9051,
            "title": "Background on neonatal encephalopathy"
        },
        {
            "endOffset": 26086,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0080",
            "sentence": "Events that do not meet the case definition should be classified in the additional categories for analysis.",
            "startOffset": 25979,
            "title": "Data analysis"
        },
        {
            "endOffset": 30161,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "All reported events of Neonatal Encephalopathy should be presented according to the categories listed in guideline 31.",
            "startOffset": 30043,
            "title": "Data presentation"
        },
        {
            "endOffset": 31803,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Guidelines for data collection, analysis, and presentation of generalized acute neonatal encephalopathy as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0105",
            "sentence": "The trial profile, indicating participant flow during a study including drop-outs and withdrawals to indicate the size and nature of the respective groups under investigation;",
            "startOffset": 31628,
            "title": "Data presentation"
        },
        {
            "endOffset": 15971,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The results were further limited to either reviews or major/prospective clinical studies.",
            "startOffset": 15882,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for neonatal encephalopathy as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 10376,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "It is therefore imperative to emphasize that many different processes leading to neonatal encephalopathy may develop prenatally, at birth or immediately post-delivery, and result from mainly, but not exclusively, genetic, metabolic, infectious, and traumatic processes.",
            "startOffset": 10107,
            "title": "Background on neonatal encephalopathy"
        }
    ],
    "docId": "S0264410X17301081",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "contact@brightoncollaboration.org",
                "first": "Erick",
                "initial": "E.",
                "last": "Sell"
            },
            {
                "email": null,
                "first": "Flor M.",
                "initial": "F.M.",
                "last": "Munoz"
            },
            {
                "email": null,
                "first": "Aung",
                "initial": "A.",
                "last": "Soe"
            },
            {
                "email": null,
                "first": "Max",
                "initial": "M.",
                "last": "Wiznitzer"
            },
            {
                "email": null,
                "first": "Paul T.",
                "initial": "P.T.",
                "last": "Heath"
            },
            {
                "email": null,
                "first": "E. D.",
                "initial": "E.D.",
                "last": "Clarke"
            },
            {
                "email": null,
                "first": "Hans",
                "initial": "H.",
                "last": "Spiegel"
            },
            {
                "email": null,
                "first": "Daphne",
                "initial": "D.",
                "last": "Sawlwin"
            },
            {
                "email": null,
                "first": "Maja",
                "initial": "M.",
                "last": "\u0160ubelj"
            },
            {
                "email": null,
                "first": "Ilia",
                "initial": "I.",
                "last": "Tikhonov"
            },
            {
                "email": null,
                "first": "Khorshid",
                "initial": "K.",
                "last": "Mohammad"
            },
            {
                "email": null,
                "first": "Sonali",
                "initial": "S.",
                "last": "Kochhar"
            },
            {
                "email": null,
                "first": null,
                "initial": null,
                "last": null
            }
        ],
        "doi": "10.1016/j.vaccine.2017.01.045",
        "firstpage": "6501",
        "issn": "0264410X",
        "keywords": [
            "Adverse event",
            "Case definition",
            "Guidelines",
            "Immunisation",
            "Neonatal encephalopathy"
        ],
        "lastpage": "6505",
        "openaccess": "Full",
        "pub_year": 2017,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Neonatal encephalopathy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data"
    }
}